Cutoff level of prostate volume to predict the efficacy of α1-D/A adrenoceptor antagonist, naftopidil

by Yasushi Tanuma, Yoshinori Tanaka, Tomoshi Okamoto
Published 2021-01-01

The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Ben...

by Yoshinori Tanaka, Yasushi Tanuma, Naoya Masumori
Published 2017-01-01

Investigation of the reasons for withdrawal from long-term treatment with mirabegron of treatment-naïve Japanese female patients with overactive bladder in the real-world clinical...

by Yoshinori Tanaka, Yasushi Tanuma, Naoya Masumori, Hirofumi Ohnishi
Published 2019-01-01

The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM stu...

by Yasushi Tanuma, Yoshinori Tanaka, Ko Takeyama, Tomoshi Okamoto
Published 2017-01-01

Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil?

by Yasushi Tanuma, Yoshinori Tanaka, Ko Takeyama, Tomoshi Okamoto
Published 2016-01-01